306 related articles for article (PubMed ID: 17158636)
1. Endothelin-1 expression correlates with atypical histological features in mammary phyllodes tumours.
Tse GM; Chaiwun B; Lau KM; Scolyer R; Lee CS; Karim RZ; Putti TC; Law BK; Lui PC; Tan PH
J Clin Pathol; 2007 Sep; 60(9):1051-6. PubMed ID: 17158636
[TBL] [Abstract][Full Text] [Related]
2. Stromal nitric oxide synthase (NOS) expression correlates with the grade of mammary phyllodes tumour.
Tse GM; Wong FC; Tsang AK; Lee CS; Lui PC; Lo AW; Law BK; Scolyer RA; Karim RZ; Putti TC
J Clin Pathol; 2005 Jun; 58(6):600-4. PubMed ID: 15917410
[TBL] [Abstract][Full Text] [Related]
3. The Wnt pathway, epithelial-stromal interactions, and malignant progression in phyllodes tumours.
Sawyer EJ; Hanby AM; Rowan AJ; Gillett CE; Thomas RE; Poulsom R; Lakhani SR; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2002 Apr; 196(4):437-44. PubMed ID: 11920740
[TBL] [Abstract][Full Text] [Related]
4. Phyllodes tumours of the breast: the role of CD34, vascular endothelial growth factor and β-catenin in histological grading and clinical outcome.
Ho SK; Thike AA; Cheok PY; Tse GM; Tan PH
Histopathology; 2013 Sep; 63(3):393-406. PubMed ID: 23772632
[TBL] [Abstract][Full Text] [Related]
5. E-cadherin expression in the epithelial components of mammary phyllodes tumors.
Tsang JY; Mendoza P; Putti TC; Karim RZ; Scolyer RA; Lee CS; Pang AL; Tse GM
Hum Pathol; 2012 Dec; 43(12):2117-23. PubMed ID: 22820000
[TBL] [Abstract][Full Text] [Related]
6. Increased epidermal growth factor receptor (EGFR) expression in malignant mammary phyllodes tumors.
Tse GM; Lui PC; Vong JS; Lau KM; Putti TC; Karim R; Scolyer RA; Lee CS; Yu AM; Ng DC; Tse AK; Tan PH
Breast Cancer Res Treat; 2009 Apr; 114(3):441-8. PubMed ID: 18443904
[TBL] [Abstract][Full Text] [Related]
7. Tumour angiogenesis and p53 protein expression in mammary phyllodes tumors.
Tse GM; Lui PC; Scolyer RA; Putti TC; Kung FY; Law BK; Lau TS; Lee CS
Mod Pathol; 2003 Oct; 16(10):1007-13. PubMed ID: 14559983
[TBL] [Abstract][Full Text] [Related]
8. Phyllodes tumours of the breast - differentiating features in core needle biopsy.
Tsang AK; Chan SK; Lam CC; Lui PC; Chau HH; Tan PH; Tse GM
Histopathology; 2011 Oct; 59(4):600-8. PubMed ID: 21916949
[TBL] [Abstract][Full Text] [Related]
9. Stromal keratin expression in phyllodes tumours of the breast: a comparison with other spindle cell breast lesions.
Chia Y; Thike AA; Cheok PY; Yong-Zheng Chong L; Man-Kit Tse G; Tan PH
J Clin Pathol; 2012 Apr; 65(4):339-47. PubMed ID: 22259180
[TBL] [Abstract][Full Text] [Related]
10. Proliferating activity in the epithelial and stromal component of fibroadenomas and phyllodes tumours of the breast.
Barwijuk-Machała M; Reszeć J; Baltaziak M; Musiatowicz B; Cylwik J
Rocz Akad Med Bialymst; 2004; 49 Suppl 1():55-7. PubMed ID: 15638374
[TBL] [Abstract][Full Text] [Related]
11. Phyllodes tumor of the breast: role of CD10 in predicting metastasis.
Al-Masri M; Darwazeh G; Sawalhi S; Mughrabi A; Sughayer M; Al-Shatti M
Ann Surg Oncol; 2012 Apr; 19(4):1181-4. PubMed ID: 22006372
[TBL] [Abstract][Full Text] [Related]
12. Progressive deregulation of the cell cycle with higher tumor grade in the stroma of breast phyllodes tumors.
Kuijper A; de Vos RA; Lagendijk JH; van der Wall E; van Diest PJ
Am J Clin Pathol; 2005 May; 123(5):690-8. PubMed ID: 15981808
[TBL] [Abstract][Full Text] [Related]
13. Phyllodes tumour of the breast: immunohistochemical study of 37 tumours using MIB1 antibody.
Kocová L; Skálová A; Fakan F; Rousarová M
Pathol Res Pract; 1998; 194(2):97-104. PubMed ID: 9584322
[TBL] [Abstract][Full Text] [Related]
14. Stromal CD10 expression in mammary fibroadenomas and phyllodes tumours.
Tse GM; Tsang AK; Putti TC; Scolyer RA; Lui PC; Law BK; Karim RZ; Lee CS
J Clin Pathol; 2005 Feb; 58(2):185-9. PubMed ID: 15677540
[TBL] [Abstract][Full Text] [Related]
15. Beta-catenin abnormalities and associated insulin-like growth factor overexpression are important in phyllodes tumours and fibroadenomas of the breast.
Sawyer EJ; Hanby AM; Poulsom R; Jeffery R; Gillett CE; Ellis IO; Ellis P; Tomlinson IP
J Pathol; 2003 Aug; 200(5):627-32. PubMed ID: 12898599
[TBL] [Abstract][Full Text] [Related]
16. Multinucleated stromal giant cells in mammary phyllodes tumours.
Tse GM; Law BK; Chan KF; Mas TK
Pathology; 2001 May; 33(2):153-6. PubMed ID: 11358046
[TBL] [Abstract][Full Text] [Related]
17. Immunohistochemical expression of homeoproteins Six1 and Pax3 in breast phyllodes tumours correlates with histological grade and clinical outcome.
Tan WJ; Thike AA; Bay BH; Tan PH
Histopathology; 2014 May; 64(6):807-17. PubMed ID: 24438019
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of epithelial-mesenchymal transition proteins Twist and Foxc2 in phyllodes tumours of the breast.
Lim JC; Koh VC; Tan JS; Tan WJ; Thike AA; Tan PH
Breast Cancer Res Treat; 2015 Feb; 150(1):19-29. PubMed ID: 25677742
[TBL] [Abstract][Full Text] [Related]
19. p53 expression in phyllodes tumours is associated with histological features of malignancy but does not predict outcome.
Feakins RM; Mulcahy HE; Nickols CD; Wells CA
Histopathology; 1999 Aug; 35(2):162-9. PubMed ID: 10460662
[TBL] [Abstract][Full Text] [Related]
20. Increased p53 protein expression in malignant mammary phyllodes tumors.
Tse GM; Putti TC; Kung FY; Scolyer RA; Law BK; Lau TS; Lee CS
Mod Pathol; 2002 Jul; 15(7):734-40. PubMed ID: 12118111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
